.

On June 28, 2016, Biocept, Inc. (the

Company

) held its 2016 Annual Meeting of Stockholders (the

Annual Meeting

). As of May 11, 2016, the record date for the Annual Meeting, 24,969,975 shares of common stock were outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, 18,680,378 shares of common stock were present in person or represented by proxy for the two proposals summarized below.

Proposal 1: Election of Directors

The Companys stockholders elected the three persons listed below to serve until the Companys 2019 Annual Meeting of Stockholders. The final voting results are as follows:

Votes For

Votes Withheld

Broker Non-Votes

David F. Hale

6,173,148

1,253,378

11,253,852

Michael W. Nall

5,976,026

1,450,500

11,253,852

M. Faye Wilson

6,327,612

1,098,914

11,253,852

Proposal 2: Ratification of the Selection of Independent Registered Public Accounting Firm

The Companys stockholders ratified the selection by the Audit Committee of Mayer Hoffman McCann P.C. as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2016. The final voting results are as follows:

Votes For

16,556,893

Votes Against

1,568,074

Abstentions

555,411

Broker Non-Votes

0

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BIOCEPT, INC.

Dated: June 29, 2016

By:

/s/ Michael W. Nall

Name:

Michael W. Nall

Title:

Chief Executive Officer

makes a similar move, sign up!

Other recent filings from the company include the following:

General form for registration of securities under the Securities Act of 1933 - Nov. 21, 2017
General form for registration of securities under the Securities Act of 1933 - Nov. 17, 2017
Biocept Reports Third Quarter 2017 Financial Results - Nov. 9, 2017

Auto Refresh

Feedback